Supreme Court Won’t Review “Line-Extension” Definition for Medicaid Drug Rebates
- January 17, 2025
The Supreme Court refused January 13 to review a Fourth Circuit decision finding the expansive regulatory definition of “line-extension” drug was not contrary to the Medicaid statute for purposes of determining rebates drug manufacturers may owe the program.
ARTICLE TAGS
You must be logged in to access this content.